CRA International Q1 revenue rises 10.5%, beats estimates
CRA International, Inc. CRAI | 0.00 |
Overview
US consulting firm's fiscal Q1 revenue rose 10.5% yr/yr, beating analyst expectations
Adjusted EPS for fiscal Q1 missed consensus, declining 10.4% yr/yr
Company returned $25.3 mln to shareholders via dividends and share repurchases
Outlook
CRA International reaffirms full-year 2026 revenue guidance of $785 mln to $805 mln
Company expects 2026 non-GAAP EBITDA margin of 12.0% to 13.0%
Result Drivers
BROAD-BASED PRACTICE GROWTH - Eight practices grew yr/yr, with Energy, Finance, Forensic Services, and Life Sciences posting double-digit revenue growth; Antitrust & Competition Economics set a new quarterly revenue record
GEOGRAPHIC EXPANSION - Revenue grew across geographies, with North America up 8.5% and international operations up 20.3% yr/yr
PORTFOLIO OPTIMIZATION COSTS - Net income decline partly reflected $2.6 mln in cash severance and non-cash charges tied to portfolio optimization actions
Company press release: ID:nBw42MCrYa
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q1 Revenue |
Beat |
$201 mln |
$193.82 mln (3 Analysts) |
Q1 Adjusted EPS |
Miss |
$1.99 |
$2.02 (3 Analysts) |
Q1 EPS |
|
$1.69 |
|
Q1 Adjusted Net Income |
|
$13.10 mln |
|
Q1 Net Income |
|
$11.10 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
Wall Street's median 12-month price target for CRA International Inc is $252.50, about 65.4% above its May 6 closing price of $152.64
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 21 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
